BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9187239)

  • 1. Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay.
    Smiljanic-Georgijev N; Rigat B; Xie B; Wang W; Mahuran DJ
    Biochim Biophys Acta; 1997 May; 1339(2):192-202. PubMed ID: 9187239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
    Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
    Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein.
    Mahuran DJ
    Biochim Biophys Acta; 1998 Jul; 1393(1):1-18. PubMed ID: 9714704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enzyme-binding region of human GM2-activator protein.
    Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
    FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
    Meier EM; Schwarzmann G; Fürst W; Sandhoff K
    J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
    Yadao F; Hechtman P; Kaplan F
    Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical consequences of mutations causing the GM2 gangliosidoses.
    Mahuran DJ
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein.
    Rigat B; Wang W; Leung A; Mahuran DJ
    Biochemistry; 1997 Jul; 36(27):8325-31. PubMed ID: 9204879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids.
    Werth N; Schuette CG; Wilkening G; Lemm T; Sandhoff K
    J Biol Chem; 2001 Apr; 276(16):12685-90. PubMed ID: 11278374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM2 ganglioside activator occurs in multiple forms.
    Novak A; Lowden JA
    Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and specificity of human GM2 activator protein.
    Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
    J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the enzymatic resistance of the GM2 ganglioside.
    Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
    Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
    [No Abstract]   [Full Text] [Related]  

  • 15. A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB.
    Schröder M; Schnabel D; Suzuki K; Sandhoff K
    FEBS Lett; 1991 Sep; 290(1-2):1-3. PubMed ID: 1915858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of GM2 activator protein with glycosphingolipids.
    Li SC; Hama Y; Li YT
    Adv Exp Med Biol; 2001; 491():351-67. PubMed ID: 14533808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ; Sandhoff K
    J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation.
    Wendeler M; Hoernschemeyer J; Hoffmann D; Kolter T; Schwarzmann G; Sandhoff K
    Eur J Biochem; 2004 Feb; 271(3):614-27. PubMed ID: 14728689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis.
    Xie B; Wang W; Mahuran DJ
    Am J Hum Genet; 1992 May; 50(5):1046-52. PubMed ID: 1570834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.